Cargando…
In question: the scientific value of preclinical safety pharmacology and toxicology studies with cell-based therapies
A new cell-based medicinal product containing human regulatory macrophages, known as Mreg_UKR, has been developed and conforms to expectations of a therapeutic drug. Here, Mreg_UKR was subjected to pharmacokinetic, safety pharmacology, and toxicological testing, which identified no adverse reactions...
Autores principales: | Broichhausen, Christiane, Riquelme, Paloma, Ahrens, Norbert, Wege, Anja K, Koehl, Gudrun E, Schlitt, Hans J, Banas, Bernhard, Fändrich, Fred, Geissler, Edward K, Hutchinson, James A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4362366/ https://www.ncbi.nlm.nih.gov/pubmed/26015968 http://dx.doi.org/10.1038/mtm.2014.26 |
Ejemplares similares
-
TIGIT(+) iTregs elicited by human regulatory macrophages control T cell immunity
por: Riquelme, Paloma, et al.
Publicado: (2018) -
Laser Ablation Inductively Coupled Plasma Mass Spectrometry: An Emerging Technology for Multiparametric Analysis of Tissue Antigens
por: Hutchinson, Robert W., et al.
Publicado: (2015) -
DHRS9 Is a Stable Marker of Human Regulatory Macrophages
por: Riquelme, Paloma, et al.
Publicado: (2017) -
Predicting Early Viral Control under Direct-Acting Antiviral Therapy for Chronic Hepatitis C Virus Using Pretreatment Immunological Markers
por: Hutchinson, James A., et al.
Publicado: (2018) -
Development of a Flow Cytometry Assay to Predict Immune Checkpoint Blockade-Related Complications
por: Schilling, Hannah-Lou, et al.
Publicado: (2021)